Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 3

Results: 35

Reconstruction of the trachea and carina: Surgical reconstruction, autologous tissue transplantation, allograft transplantation, and bioengineering.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 284, doi. 10.1111/1759-7714.14315

By:

Ren, Jianghao;
Xu, Yuanyuan;
Zhiyi, Guo;
Ren, Ting;
Ren, Jiangbin;
Wang, Kan;
Luo, Yiqing;
Zhu, Mingyang;
Tan, Qiang

Publication type:

Article

Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between different lesions.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 514, doi. 10.1111/1759-7714.14295

By:

Sun, Mengyao;
Wang, Xu;
Xu, Yinghui;
Sun, Chao;
Guo, Ye;
Qiu, Shi;
Zhao, Renshan;
Zhu, Wenhao;
Ma, Kewei

Publication type:

Article

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 510, doi. 10.1111/1759-7714.14293

By:

Okano, Yoshio;
Kunishige, Michihiro;
Kondo, Yoshihiro;
Kadota, Naoki;
Morishita, Atsushi;
Naruse, Keishi;
Machida, Hisanori;
Hatakeyama, Nobuo;
Hino, Hiroyuki;
Shinohara, Tsutomu;
Sakiyama, Shoji;
Takeuchi, Eiji

Publication type:

Article

Left sleeve pneumonectomy via uniportal video‐assisted thoracoscopic approach.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 506, doi. 10.1111/1759-7714.14292

By:

Cai, Jianqiao;
Song, Nan;
Jiang, Lei

Publication type:

Article

Use of PD‐1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 502, doi. 10.1111/1759-7714.14290

By:

Xu, Li;
Tao, Ning‐ning;
Liang, Bin;
Li, Dao‐wei;
Li, Huai‐chen;
Su, Li‐li

Publication type:

Article

miR‐223‐3p targets FBXW7 to promote epithelial‐mesenchymal transition and metastasis in breast cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 474, doi. 10.1111/1759-7714.14284

By:

Wang, Yuli;
Shi, Shuang;
Wang, Yunshan;
Zhang, Xuhua;
Liu, Xiaoyan;
Li, Juan;
Li, Peilong;
Du, Lutao;
Wang, Chuanxin

Publication type:

Article

Preoperative electromagnetic navigation bronchoscopy‐guided one‐stage multiple‐dye localization for resection of subsolid nodules: A single‐center pilot study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 466, doi. 10.1111/1759-7714.14283

By:

Jeong, Jong Hwan;
Park, Hyeongbin;
Choi, Chang‐Min;
Oh, Ju Hyun;
Lee, Geun Dong;
Kim, Dong Kwan;
Hwang, Hee Sang;
Jang, Se Jin;
Oh, Sang Young;
Kim, Mi Young;
Ji, Wonjun

Publication type:

Article

Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 460, doi. 10.1111/1759-7714.14282

By:

Takamori, Satoshi;
Ishikawa, Shigeo;
Suzuki, Jun;
Oizumi, Hiroyuki;
Uchida, Tetsuro;
Ueda, Shohei;
Edamatsu, Kaoru;
Iino, Mitsuyoshi;
Sugimoto, Masahiro

Publication type:

Article

Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 453, doi. 10.1111/1759-7714.14281

By:

Tamura, Tomoki;
Ninomiya, Kiichiro;
Kubo, Toshio;
Kuyama, Shoichi;
Tachibana, Sayaka;
Inoue, Koji;
Chikamori, Kenichi;
Kudo, Kenichiro;
Ochi, Nobuaki;
Harada, Daijiro;
Maeda, Yoshinobu;
Kiura, Katsuyuki

Publication type:

Article

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 442, doi. 10.1111/1759-7714.14280

By:

Feng, Yuan;
Sun, Wei;
Zhang, Jie;
Wang, Yang;
Chen, Jinfeng;
Liu, Xinying;
Wang, Liang;
Li, Shaolei;
Lv, Chao;
Lu, Fangliang;
Zhang, Jianzhi;
Hong, Yang;
Xiao, Shanshan;
Wang, Tao;
Jiao, Raymond;
Wang, Ziping;
Qi, Liping;
Li, Nan;
Yang, Yue;
Lin, Dongmei

Publication type:

Article

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 497, doi. 10.1111/1759-7714.14279

By:

Yao, Yanhong;
Liu, Zhentao;
Li, Qian;
Cao, Baoshan;
Wang, Mopei

Publication type:

Article

MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 430, doi. 10.1111/1759-7714.14278

By:

Li, Yang;
Zu, Lingling;
Wu, Heng;
Zhang, Fang;
Fan, Yaguang;
Pan, Hongli;
Du, Xinxin;
Guo, Fengjie;
Zhou, Qinghua

Publication type:

Article

Update on adjuvant therapy in completely resected NSCLC patients.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 277, doi. 10.1111/1759-7714.14277

By:

Lim, Jeong Uk;
Yeo, Chang Dong

Publication type:

Article

Successful erlotinib rechallenge in an EGFR‐mutant metastatic non‐small cell lung cancer patient with afatinib‐induced drug rash with eosinophilia and systemic symptoms: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 494, doi. 10.1111/1759-7714.14276

By:

Lin, Chung‐Fu;
Liu, Szu‐Yu;
Lo, Tzu‐Kun;
Lee, Julia Yu‐Yun;
Su, Po‐Lan

Publication type:

Article

"Split" combined subsegmentectomy: A case series.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 423, doi. 10.1111/1759-7714.14275

By:

Hong, Ruopeng;
Chen, Chun;
Zheng, Wei;
Zheng, Bin;
Xu, Chi;
Xu, Guobing

Publication type:

Article

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 412, doi. 10.1111/1759-7714.14274

By:

Shi, Yuequan;
Fang, Jian;
Zhou, Chengzhi;
Liu, Anwen;
Wang, Yan;
Meng, Qingwei;
Ding, Cuimin;
Ai, Bin;
Gu, Yangchun;
Yao, Yu;
Sun, Hong;
Guo, Hui;
Zhang, Cuiying;
Song, Xia;
Li, Junling;
Xu, Bei;
Han, Zhiqiang;
Song, Meijun;
Tang, Tingyu;
Chen, Peifeng

Publication type:

Article

Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 404, doi. 10.1111/1759-7714.14273

By:

Bao, Yongxing;
Yang, Xu;
Men, Yu;
Kang, Jingjing;
Sun, Xin;
Zhao, Maoyuan;
Sun, Shuang;
Yuan, Meng;
Ma, Zeliang;
Hui, Zhouguang

Publication type:

Article

Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 394, doi. 10.1111/1759-7714.14271

By:

Long, Yaping;
Xiong, Qi;
Song, Qi;
Li, Yao;
Li, Xiaoyan;
Qin, Boyu;
Huang, Ziwei;
Hu, Yi;
Yang, Bo

Publication type:

Article

Tumor‐associated macrophages: An important player in breast cancer progression.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 269, doi. 10.1111/1759-7714.14268

By:

Huang, Xinqun;
Cao, Jingsong;
Zu, Xuyu

Publication type:

Article

Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 386, doi. 10.1111/1759-7714.14267

By:

Ito, Takashi;
Nagashima, Hiromi;
Akiyama, Masachika;
Utsumi, Yu;
Sato, Hideomi;
Chiba, Shinji;
Sugai, Mayu;
Ube, Kenji;
Mori, Yoshiaki;
Watanabe, Kana;
Fukuhara, Tatsuro;
Maemondo, Makoto

Publication type:

Article

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 380, doi. 10.1111/1759-7714.14266

By:

Lee, Su Yeon;
Kim, Young Chul;
Lee, Kye Young;
Lee, Sung Yong;
Lee, Shin Yup;
Lee, Min Ki;
Lee, Jeong Eun;
Jang, Seung Hun;
Jang, Tae‐Won;
Choi, Chang Min

Publication type:

Article

Optimal duration of adjuvant bisphosphonate treatment for high‐risk early breast cancer: Results from a SUCCESS trial.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 519, doi. 10.1111/1759-7714.14257

By:

Lu, Mingbei;
Ren, Beibei;
Rao, Lingyan

Publication type:

Article

Risk factors for pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 361, doi. 10.1111/1759-7714.14263

By:

Kim, Ha Eun;
Yu, Woo Sik;
Lee, Chang Young;
Lee, Jin Gu;
Kim, Dae Joon;
Park, Seong Yong

Publication type:

Article

Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 353, doi. 10.1111/1759-7714.14259

By:

Xie, Mengqing;
Yu, Xin;
Chu, Xiangling;
Xie, Huikang;
Zhou, Juan;
Zhao, Jing;
Su, Chunxia

Publication type:

Article

Uniportal video‐assisted thoracic surgery approach for simultaneous lung cancer and thymic carcinoma: Case report and literature review.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 489, doi. 10.1111/1759-7714.14258

By:

Frasca, Luca;
Tacchi, Giovanni;
Longo, Filippo;
Marziali, Valentina;
De Peppo, Valerio;
Moscardelli, Alessandro;
Crucitti, Pierfilippo

Publication type:

Article

Colorectal cancer‐related pulmonary metastasectomy: Factors affecting survival time.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 517, doi. 10.1111/1759-7714.14240

By:

Williams, Norman R.;
Macbeth, Fergus;
Treasure, Tom

Publication type:

Article

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 369, doi. 10.1111/1759-7714.14265

By:

Zhou, Bodong;
Zhu, Wenbo;
Yuan, Shuai;
Wang, Yifei;
Zhang, Qing;
Zheng, Hong;
Zhu, Lei;
Xu, Jie

Publication type:

Article

Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 346, doi. 10.1111/1759-7714.14255

By:

Tseng, Yen‐Chiang;
Hsu, Han‐Shui;
Lin, Yi‐Hsuan;
Tseng, Yen‐Han;
Shu, Chih‐Wen;
Goan, Yih‐Gang;
Tseng, Ching‐Jiunn

Publication type:

Article

ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 338, doi. 10.1111/1759-7714.14249

By:

Hu, Chunfang;
Dong, Jiyan;
Liu, Li;
Liu, Jingbo;
Sun, Xujie;
Teng, Fei;
Wang, Xin;
Ying, Jianming;
Li, Junling;
Xing, Puyuan;
Yang, Lin

Publication type:

Article

Efficacy and safety of anti‐PD‐1/PD‐L1 in combination with chemotherapy or not as first‐line treatment for advanced non‐small cell lung cancer: A systematic review and network meta‐analysis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 322, doi. 10.1111/1759-7714.14244

By:

Wang, Liming;
Yang, Yifan;
Yu, Jiangyong;
Zhang, Shuai;
Li, Xu;
Wu, Xiaonan;
Nie, Xin;
Liu, Wenbo;
Zhang, Ping;
Li, Yi;
Li, Ailing;
Ai, Bin

Publication type:

Article

MicroRNA‐21 was a promising biomarker for lung carcinoma diagnosis: An update meta‐analysis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 316, doi. 10.1111/1759-7714.14242

By:

Wang, Haiyan;
Xu, Jia;
Ding, Ling

Publication type:

Article

Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 483, doi. 10.1111/1759-7714.14256

By:

Banna, Giuseppe L.;
Tiseo, Marcello;
Cortinovis, Diego L.;
Facchinetti, Francesco;
Aerts, Joachim G. J. V.;
Baldessari, Cinzia;
Giusti, Raffaele;
Bria, Emilio;
Grossi, Francesco;
Berardi, Rossana;
Morabito, Alessandro;
Catino, Annamaria;
Genova, Carlo;
Mazzoni, Francesca;
Gelibter, Alain;
Rastelli, Francesca;
Macerelli, Marianna;
Chiari, Rita;
Gori, Stefania;
Mansueto, Giovanni

Publication type:

Article

Effect of physical manipulation pulmonary rehabilitation on lung cancer patients after thoracoscopic lobectomy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 308, doi. 10.1111/1759-7714.14225

By:

Zhou, Ting;
Sun, Chao

Publication type:

Article

Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 3, p. 296, doi. 10.1111/1759-7714.14218

By:

Yang, Yufan;
Zhang, Tao;
Zhou, Zongmei;
Liang, Jun;
Chen, Dongfu;
Feng, Qinfu;
Xiao, Zefen;
Hui, Zhouguang;
Lv, Jima;
Deng, Lei;
Wang, Xin;
Wang, Wenqing;
Wang, Jianyang;
Liu, Wenyang;
Zhai, Yirui;
Wang, Jie;
Bi, Nan;
Wang, Luhua

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2022, v. 13, n. 3, p. 267, doi. 10.1111/1759-7714.14017
Publication type:: Article